• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Pharmacology - practical courses
Pharmacology - practical courses

... /1/ INTRODUCTION TO THE STUDY OF PHARMACOLOGY Contents and organisation of practical courses and lectures, required and recommended textbooks. Conditions for credit. Pharmacology - definition, basic terminology, subspecializations, drug nomenclature. Introduction to the prescription terminology. Cla ...
Lecture 01 - Cal State LA
Lecture 01 - Cal State LA

... •Examine features of inactive small molecules (ligands) and the features of active small molecules (ligands). •Generate a hypothesis about what chemical groups on the ligand are necessary for biological function; what chemical ...
(rhGH) functional quality characterization by LC/CE-MS and
(rhGH) functional quality characterization by LC/CE-MS and

Vacancy Senior Scientist Translational Medicine
Vacancy Senior Scientist Translational Medicine

Biologics for the respiratory physician - SGUL
Biologics for the respiratory physician - SGUL

... • The classical autoantibodies, or rheumatoid factors, have long been known; more recently discovered are IgG Abs to deiminated citrullinated proteins. • Cytokines augment HLA expression and Ag presentation to T cells in local autoimmune disease sites like synovial joints • Cytokine research was pro ...
AIJG-61999
AIJG-61999

... “The phytoestrogens, although not as potent as the human estrogens produced by the human body, may be able to moderate the influence of estrogen and thus be a stabilizing factor throughout the hormonal cycles. This stabilization may promote the long-term health of the reproductive system, including ...
Clinical Pharmacology 1 - M
Clinical Pharmacology 1 - M

01_CLIN_PHARMACOKYNETIC_PHARMACODYNAMIC
01_CLIN_PHARMACOKYNETIC_PHARMACODYNAMIC

... fluid, and delivered to the small intestine (which has a large surface area for absorption of nutrients and drugs) before they are absorbed. Liquid medications are absorbed faster than tablets or capsules because they need not be dissolved. ...
Variability in Drug Response 2
Variability in Drug Response 2

Peds Dx 2001
Peds Dx 2001

... Special analysis for dextromethorphan was positive ...
TERATOGENITY of DRUGS
TERATOGENITY of DRUGS

... 30 (6.4 %) of treatments unlikely to pose a risk in human pregnancy ...
- Applied Science University
- Applied Science University

... To be able to discuss and explain the effects of drug structure and physicochemical properties on pharmacokinetics (drug absorption, distribution, metabolism and excretion), pharmacodynamics (reaction of drug with respective receptor), drug latentiation (prodrugs) and drug metabolism (chemical modif ...
Document
Document

... Survey of methods with scale-up of each investigated ...
clinical trials
clinical trials

Synthetic Drugs What every parent and caregiver needs to know
Synthetic Drugs What every parent and caregiver needs to know

... Often marketed as “legal high” Labeled “not for human consumption” in order to avoid FDA regulation Manu factors constantly manipulate molecular structure of chemicals in order to avoid new legislation that bans known synthetic drugs Often sold as “bath salts” or “incense” and other common household ...
AN: 00153/2013 Revised: August 2013 SUMMARY OF PRODUCT
AN: 00153/2013 Revised: August 2013 SUMMARY OF PRODUCT

... within the first two hours of trauma for maximum clinical benefit. The need for conjunctive surgery or other medicinal treatment should be considered according to individual clinical status. Following use at high dosage, there is no need for gradual tailing off, i.e. therapy can be stopped as soon a ...
Synthetic drugs: Popular but dangerous
Synthetic drugs: Popular but dangerous

... “The main reason this product has become so popular is that it’s legal,” Cannon said. “It also does not show up in a standard urine drug test.” That’s one reason some people who smoke regular marijuana prefer the synthetic variety because they can smoke it without any legal ramifications, she added. ...
Designing concept maps for a precise and objective
Designing concept maps for a precise and objective

... When evaluating a new manufactured product with respect to existing treatments, physicians must first identify the set of drugs used for a given indication, and then study the monographs for each drug in the set, section by section, comparing the properties of each drug with those of the new drug. T ...
ULM COLLEGE OF PHARMACY Drug Information Center 318
ULM COLLEGE OF PHARMACY Drug Information Center 318

... Samsca (tolvaptan): FDA Limits Use Due to Possible Liver Injury The FDA has limited the duration and usage of the drug due to evidence suggesting possible severe adverse effects possibly leading to liver transplant or death. View Alert FDA Warns of Adverse Effects Linked to Anti-Seizure Medication P ...
Herbal Remedies and Drug Interactions
Herbal Remedies and Drug Interactions

...  Inhibits platelet activity, so it should not be taken concurrently with warfarin or other drugs that affect clotting.  A member of the daisy family, it is contraindicated in patients with allergy to ...
NEXT-GENERATION DATA ANALYSIS SOFTWARE AIDS FASTER
NEXT-GENERATION DATA ANALYSIS SOFTWARE AIDS FASTER

... Faster and better drug development can reduce the time taken to make safe and effective drugs available to those who need them most. The pharmaceutical scientists in academia, the pharmaceutical industry, and regulatory agencies such as the Food and Drug Administration (FDA) have been greatly intere ...
Basic Principles of Pharmacology
Basic Principles of Pharmacology

... development of cancer ...
Grapefruit to Glaucoma
Grapefruit to Glaucoma

... of muscle damage. Patients taking simvastatin 80 mg daily have an increased risk of myopathy compared to patients taking lower doses of this drug or other drugs in the same class. This risk appears to be higher during the first year of treatment, is often the result of interactions with certain medi ...
Oxcarbazepine (TrileptalTM)
Oxcarbazepine (TrileptalTM)

... The Epilepsy Foundation is seriously concerned about mandatory substitution of generic antiepileptic drugs without prior approval of the patient and treating physician. Because changing from one formulation of an AED to another can usually be accomplished, and risks minimized, if physicians and pati ...
Antibodies – The “Magic Bullets” for Drug Delivery?
Antibodies – The “Magic Bullets” for Drug Delivery?

... Keywords: Antibodies; Drug; Pharmacokinetics; Pharmacodynamics The idea of “magic bullet”, of a drug that would seek out the locus of disease and “cure” it remains to this day a fantasy, a science fiction. In 2014, I published an article on “Targeting Drug-Delivery Systems: Promises, Promises, and M ...
< 1 ... 146 147 148 149 150 151 152 153 154 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report